retatrutide in Phase III Metabolic focus: Obesity, overweight, type 2 diabetes, sleep apnea, osteoarthritis, MASLD/MASH and cardiovascular/renal outcomes Eli Lillys obesity portfolio includes Zepbound, the newly approved oral GLP-1 drug Foundayo and the Phase III candidate retatrutide
The CBUM Series Itholate Protein is 100% micro-filtered whey isolate, boasting 25g of high-quality protein per scoop with optimal digestibility
Heavy coffee consumption and plasma homocysteine: a randomized controlled trial in healthy volunteers
5 If testing is not possible, remember: When in doubt, treat. Untreated hypoglycemia presents a greater risk than that posed by an episode of hyperglycemia
Oral administration of Dihexa achieves 4060% bioavailability with slower absorption kinetics compared to subcutaneous injection, potentially reducing the need for daily dosing due to sustained plasma concentrations